These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6850093)

  • 21. Anticomplementary effects developed in vitro by two xenogeneic skin extracts on human sera.
    Dioguardi D; Favoino B; Laurentaci G
    Panminerva Med; 1983; 25(3):191-2. PubMed ID: 6669395
    [No Abstract]   [Full Text] [Related]  

  • 22. Genes and proteins in immunity.
    Biochem Soc Symp; 1986; 51():1-235. PubMed ID: 3101695
    [No Abstract]   [Full Text] [Related]  

  • 23. Interactions of immunoglobulins outside the antigen-combining site.
    Nezlin R; Ghetie V
    Adv Immunol; 2004; 82():155-215. PubMed ID: 14975257
    [No Abstract]   [Full Text] [Related]  

  • 24. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
    Wagner E; Platt JL; Frank MM
    J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble HLA antigens not detected in human immunoglobulin preparations.
    McLean IL; Faed JM; Milligan LM; Adams DD
    Tissue Antigens; 1983 Jul; 22(1):59-61. PubMed ID: 6612705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of antibody-dependent cell-mediated cytotoxicity by anti-immunoglobulin. I. Relationship to target cell capping.
    Halloran PF; Stylianos SK
    Clin Exp Immunol; 1980 Oct; 42(1):127-35. PubMed ID: 6970095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-opsonin effect of extracellular staphylococcal products].
    Bukharin OV; Deriabin DG; Brudastov IuA
    Biull Eksp Biol Med; 1994 Jun; 117(6):639-41. PubMed ID: 8068924
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 29. Protection from complement-mediated cytolysis in cross-species hepatocytes transfected with complement regulatory factor (HRF20) using retroviral vector.
    Hayashi S; Isobe K; Emi N; Kasai Y; Yokoyama I; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1252. PubMed ID: 7518121
    [No Abstract]   [Full Text] [Related]  

  • 30. The relevance of complement to virus biology.
    Blue CE; Spiller OB; Blackbourn DJ
    Virology; 2004 Feb; 319(2):176-84. PubMed ID: 15015499
    [No Abstract]   [Full Text] [Related]  

  • 31. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 32. [Features of the immune status in acute pancreatitis].
    Tarasenko VS; Smoliagin AI; Kubyshkin VA
    Khirurgiia (Mosk); 2000; (8):51-5. PubMed ID: 10997008
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement-opsonized HIV: the free rider on its way to infection.
    Stoiber H; Pruenster M; Ammann CG; Dierich MP
    Mol Immunol; 2005 Feb; 42(2):153-60. PubMed ID: 15488605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Humoral immunity].
    Pasquali JL; Korganow AS
    Rev Prat; 1998 Feb; 48(3):337-42. PubMed ID: 9781085
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytotoxicity by stored human breast-milk: possible contribution of complement system.
    Ogundele MO
    Cell Biol Int; 1999; 23(8):585-8. PubMed ID: 10704243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of anticomplementary activity from human immune serum globulins by treatment with purified human plasmin.
    Liu DT; Grzenczyk BS; Pai RC
    Transfusion; 1979; 19(3):261-7. PubMed ID: 156418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
    Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
    J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes.
    Sándor N; Pap D; Prechl J; Erdei A; Bajtay Z
    Mol Immunol; 2009 Dec; 47(2-3):438-48. PubMed ID: 19796821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic inhibition of the complement system.
    Makrides SC
    Pharmacol Rev; 1998 Mar; 50(1):59-87. PubMed ID: 9549758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Components of the immune system].
    Santaella ML
    Bol Asoc Med P R; 1981 Apr; 73(4):132-5. PubMed ID: 6946778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.